Skip to main content
Part of Sickle Cell Disease on Somebody To Talk To

Clinical Trials and Research1 min read

Sickle Cell Disease Linked to Higher Postpartum LARC Use

About this article

Published
Last updated
Further reading
Read More(opens in a new tab)
medscape

TOPLINE

People with sickle cell disease (SCD) had 82% higher odds of receiving immediate postpartum long-acting reversible contraception (LARC) than those without SCD in a study.

METHODOLOGY

  • A cross-sectional study analyzed 29,822,518 delivery hospitalizations from the 2012-2019 National Inpatient Sample, including 18,860 deliveries among people with SCD and 29,803,658 among people without SCD.
  • Researchers evaluated rates of immediate postpartum LARC uptake (intrauterine device or contraceptive implant) during delivery admissions for live births and stillbirths among individuals aged 12-55 years. A subanalysis restricted to deliveries among Black individuals was also conducted.
  • Multivariate logistic regression adjusted for maternal age, delivery mode, presence of severe maternal morbidity, insurance type, median household income, region, hospital type, and calendar year.
Share